Patrick Mahieux

Mahieux brings a wealth of experience in the pharmaceutical industry to SK pharmteco. Most recently, he served as CEO of ABL Europe where he successfully drove a 30% yearly growth from 2016 to 2022 by doubling the company’s capacity through strategic site acquisitions. His expertise in scaling operations and driving business growth will be instrumental in expanding SK pharmteco’s footprint in the European cell and gene therapy market.